A SIMPLE KEY FOR BMY-27709 UNVEILED

g. IPF and scleroderma), but the pathophysiology of such designs, counting on direct administration of drug to tissue, differs considerably from medical bleomycin‐induced lung fibrosis. Alternatively, systemic administration of a pro‐fibrotic drug like bleomycin should really far more closely mimic the inflammatory and fibrotic procedures obser